Relacorilant
CORT125134-552
Phase 2 small_molecule completed
Quick answer
Relacorilant for Recurrent Ovarian Cancer is a Phase 2 program (small_molecule) at CORCEPT THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Recurrent Ovarian Cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed